van Houte Hans
CIK 1817217
Transactions on file
30
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-01-30 | 2025-01-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 3,750 | $0.00 | — | open → |
| 2025-01-30 | 2025-01-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,557 | $50.7K | -22.8% | open → |
| 2025-01-30 | 2025-01-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 254 | $5.2K | -24.7% | open → |
| 2025-01-30 | 2025-01-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,000 | $0.00 | — | open → |
| 2025-01-30 | 2025-01-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,886 | $0.00 | — | open → |
| 2025-03-03 | 2025-03-03 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 5,125 | $73.8K | +6.3% | open → |
| 2025-03-03 | 2025-03-03 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 700 | $10.6K | +1.1% | open → |
| 2025-04-30 | 2025-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,438 | $28.0K | +33.0% | open → |
| 2025-04-30 | 2025-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 3,750 | $0.00 | — | open → |
| 2025-04-30 | 2025-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,886 | $0.00 | — | open → |
| 2025-04-30 | 2025-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,000 | $0.00 | — | open → |
| 2025-05-02 | 2025-05-02 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 6,198 | $70.2K | +35.0% | open → |
| 2026-05-05 | 2026-05-05 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 582 | $10.0K | -10.9% | open → |
| 2026-05-05 | 2026-05-05 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 13,473 | $223.3K | -7.7% | open → |
| 2026-04-30 | 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,388 | $39.7K | -8.1% | open → |
| 2026-04-30 | 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,858 | $0.00 | — | open → |
| 2026-04-30 | 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 3,750 | $0.00 | — | open → |
| 2026-04-30 | 2026-04-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,000 | $0.00 | — | open → |
| 2025-11-03 | 2025-11-03 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 6,284 | $78.9K | +21.8% | open → |
| 2025-10-30 | 2025-10-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 3,130 | $40.1K | +19.6% | open → |
| 2025-10-30 | 2025-10-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,858 | $0.00 | — | open → |
| 2025-10-30 | 2025-10-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 3,750 | $0.00 | — | open → |
| 2025-10-30 | 2025-10-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,000 | $0.00 | — | open → |
| 2025-10-30 | 2025-10-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,886 | $0.00 | — | open → |
| 2025-07-30 | 2025-07-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,858 | $0.00 | — | open → |
| 2025-07-30 | 2025-07-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 4,304 | $51.7K | +27.4% | open → |
| 2025-07-30 | 2025-07-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,886 | $0.00 | — | open → |
| 2025-07-30 | 2025-07-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 2,000 | $0.00 | — | open → |
| 2025-07-30 | 2025-07-30 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 3,750 | $0.00 | — | open → |
| 2025-08-01 | 2025-08-01 | NRIX Nurix Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 5,402 | $59.6K | +38.7% | open → |
